Skip to main content
. 2025 Feb 6;15(2):245. doi: 10.3390/life15020245
ASCVD atherosclerovascular disease
LDL low-density lipoprotein
HDL high-density lipoprotein
oxLDL oxidized low-density lipoprotein
VEGF vascular endothelial growth factor
TNF-α tumor necrosis factor-alpha
IL interleukin
IFN-γ interferon-gamma
SASP senescence-associated secretory phenotype
ROS reactive oxygen species
DDR DNA damage response
NO nitric oxide
PGI2 prostacyclin
TS3 Type III Secretion System
Hfq Host Factor for RNA Binding
mTOR mammalian target of rapamycin
HMGCR 3-hydroxy-3-methylglutaryl-coenzyme a reductase
LXR-α liver X receptor-alpha
PPAR-γ peroxisome proliferator-activated receptor-gamma
ABCA1 ATP-binding cassette transporter A1
ApoB apolipoprotein B
GDP Guanosine Diphosphate
5-FU 5-fluorouracil
TG triglyceride
ICAM-1 Intercellular Adhesion Molecule 1
VCAM-1 Vascular Cell Adhesion Molecule 1
ADT androgen deprivation therapy
SERMs selective estrogen receptor modulators
AIs aromatase inhibitors
TKIs tyrosine kinase inhibitors
PD-1 Programmed Death-1
CTLA4 Cytotoxic T-Lymphocyte-Associated Protein 4
CVD cardiovascular disease
CRP C-reactive protein
ARB angiotensin receptor blocker
CVAD cardiovascular adverse disease
TMA trimethylamine
TMAO trimethylamine-N-oxide
SCFAs short-chain fatty acids